Your browser doesn't support javascript.
loading
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.
Satoh, Taroh; Lee, Kyung Hee; Rha, Sun Young; Sasaki, Yasutsuna; Park, Se Hoon; Komatsu, Yoshito; Yasui, Hirofumi; Kim, Tae-You; Yamaguchi, Kensei; Fuse, Nozomu; Yamada, Yasuhide; Ura, Takashi; Kim, Si-Young; Munakata, Masaki; Saitoh, Soh; Nishio, Kazuto; Morita, Satoshi; Yamamoto, Eriko; Zhang, Qingwei; Kim, Jung-mi; Kim, Yeul Hong; Sakata, Yuh.
Afiliação
  • Satoh T; Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan.
  • Lee KH; Hemato-Oncology, Internal Medicine, Yeungnam University Hospital, Daegu, Republic of Korea.
  • Rha SY; Medical Oncology, Internal Medicine, Yonsei Cancer Center, Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Sasaki Y; Medical Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Park SH; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea.
  • Komatsu Y; Division of Cancer Chemotherapy, Hokkaido University Hospital, Hokkaido, Japan.
  • Yasui H; Division of GI Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Kim TY; Hematology-Oncology, Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Yamaguchi K; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Fuse N; Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Yamada Y; Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Kim SY; Department of Medical Oncology and Hematology, Kyung Hee University Hospital, Seoul, Republic of Korea.
  • Munakata M; Internal Medicine, Misawa Municipal Hospital, Aomori, Japan.
  • Saitoh S; Medical Oncology and Gastroenterology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Nishio K; Department of Genome Biology, Kinki University School of Medicine, Osaka, Japan.
  • Morita S; Department of Biostatics and Epidemiology, Yokohama City University, Kanagawa, Japan.
  • Yamamoto E; Clinical Development Department II, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Zhang Q; Clinical Data and Biostatistics Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Kim JM; Medical and Regulatory Affairs Department, Kuhnil Pharm. Co., Ltd., Seoul, Republic of Korea.
  • Kim YH; Department of Internal Medicine, Section of Hemato-Oncology, Korea University Anam Hospital, 126-1 Anam-dong 5ga, Seongbuk-gu, Seoul, 136-705, Republic of Korea. yhk0215@korea.ac.kr.
  • Sakata Y; Internal Medicine, Misawa Municipal Hospital, Aomori, Japan.
Gastric Cancer ; 18(4): 824-32, 2015 Oct.
Article em En | MEDLINE | ID: mdl-25185971
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão